4-Ethyl-3-{[(4-methylphenyl)methyl]sulfanyl}-5-{thieno[2,3-b]quinolin-2-yl}-4H-1,2,4-triazole

Catalog No. :
ACIRBF017
CAS No. :
439112-39-7
Molecular Formula :
C23H20N4S2
Molecular Weight :
416.58

IUPAC Name:2-(4-ethyl-5-((4-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)thieno[2,3-b]quinoline

4-Ethyl-3-{[(4-methylphenyl)methyl]sulfanyl}-5-{thieno[2,3-b]quinolin-2-yl}-4H-1,2,4-triazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Ethyl-3-{[(4-methylphenyl)methyl]sulfanyl}-5-{thieno[2,3-b]quinolin-2-yl}-4H-1,2,4-triazole
IUPAC Name2-(4-ethyl-5-((4-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)thieno[2,3-b]quinoline
Molecular FormulaC23H20N4S2
Molecular Weight416.58
SMILESCC1=CC=C(CSC2=NN=C(C3=CC4=CC5=CC=CC=C5N=C4S3)N2CC)C=C1
InChI KeyGDPSXFAYUCHSNV-UHFFFAOYSA-N
Synonym4-ETHYL-5-THIENO[2,3-B]QUINOLIN-2-YL-4H-1,2,4-TRIAZOL-3-YL 4-METHYLBENZYL SULFIDE;2-(4-ETHYL-5-[(4-METHYLBENZYL)SULFANYL]-4H-1,2,4-TRIAZOL-3-YL)THIENO[2,3-B]QUINOLINE;4-ethyl-3-{[(4-methylphenyl)methyl]sulfanyl}-5-{thieno[2,3-b]quinolin-2-yl}-4H-1,2,4-triazole;Thieno[2,3-b]quinoline, 2-[4-ethyl-5-[[(4-methylphenyl)methyl]thio]-4H-1,2,4-triazol-3-yl]-
CAS No.439112-39-7

Synthetic Route by SureRoute

1. ACIRBF017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRBF017 route product structure diagram
    ACIRBF017439112-39-7
Inquiry

2. ACIRBF017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRBF017 route product structure diagram
    ACIRBF017439112-39-7
Inquiry

Comments (0)